EDP Biotech Corporation is a privately held medical device company focused on the development and commercialization of immunodiagnostic tests. EDP performs research and develops products to identify proteins present in the early stages of biological changes for production of in vitro diagnostic tests whose primary target is early detection. EDP’s primary product, then new and improved 2nd Generation ColoPlex™, is a blood-based biomarker assay to be used in the early detection of colorectal cancer. ColoPlex™ test is currently in the research and development stage and is not yet available for sale or research use in any country.
Contact Us for Additional Information
For additional information on EDP Biotech Corporation or about our products please fill in the requested information. A representative from EDP Biotech Corporation will respond to your inquiry by email or phone. The email address you provide will only be used to respond to your inquiry. We do not sell or share your personal information with outside third parties.
If you are interested in becoming a Distributor visit our Distributor Opportunities Page.
If you have general questions about EDP or ColoPlex™ visit our Contact Us Page.